Teva Pharm Indus (TEVJF) Stock Price, News & Analysis
Teva Pharm Indus (TEVJF) last traded on July 21, 2026. A Form 25-NSE filed on September 14, 2026 removes its shares from exchange listing.
Price Move History
- Daily moves over 5%
- 4 10 sessions, August 8, 2025 to July 21, 2026
- Largest daily move
- -13.9% close of July 21, 2026
- 1-month change
- -6.4% closing prices, June 4, 2026 to July 21, 2026
Company Description
Teva Pharm Indus (TEVJF) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector.
TEVJF declined 6.4% in the month to July 21, 2026. The last closing price was $28.40.
For FY2025, Teva Pharm Indus reported revenue of $17.3B with net income of $1.4B and diluted earnings per share of $1.21. The company operates at a net profit margin of 8.2%.
This page collects what Stock Titan holds for TEVJF, including price data, SEC filings, financial highlights, and short interest trends.
Stock Performance
Teva Pharm Indus (TEVJF) closed at $28.40 on July 21, 2026. In the month to July 21, 2026, the price lost 6.4%.
TEVJF Metrics & Rankings
Price returns through July 21, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
Teva Pharm Indus has filed 10 recent SEC filings, including 5 Form 8-K, 2 Form 144, 1 Form 4, 1 Form 25-NSE. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all TEVJF SEC filings →
Financial Highlights
Teva Pharm Indus generated $17.3B in revenue in FY2025, retaining a 51.8% gross margin, operating income reached $2.2B (12.5% operating margin), and net income was $1.4B, reflecting a 8.2% net profit margin. Diluted earnings per share stood at $1.21. The company generated $1.6B in operating cash flow. The current ratio was 1.04, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in Teva Pharm Indus (TEVJF) currently stands at 272.1 thousand shares, up 14.1% from the previous reporting period, representing 0.0% of the float. Since November 2025, short interest has decreased by 76.1%.
Days to Cover History
Days to cover for Teva Pharm Indus (TEVJF) currently stands at 1000.0 days. The ratio is the reported short interest divided by the average daily trading volume.
TEVJF Company Profile & Sector Positioning
Teva Pharm Indus (TEVJF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector.
Investors comparing TEVJF often look at related companies in the same sector, including Merck KGaA (MKGAF), Merck KGaA (MKKGY), Takeda Pharm Co Ltd (TKPHF), Galderma Group AG (GALDY), and Galderma Group AG (GDERF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate TEVJF's relative position within its industry.